These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 29768321

  • 21. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Schilsky ML.
    Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
    [Abstract] [Full Text] [Related]

  • 22. Wilson's disease in pregnancy: five successful consecutive pregnancies of the same woman.
    Furman B, Bashiri A, Wiznitzer A, Erez O, Holcberg G, Mazor M.
    Eur J Obstet Gynecol Reprod Biol; 2001 Jun; 96(2):232-4. PubMed ID: 11384817
    [Abstract] [Full Text] [Related]

  • 23. Transient fetal myelosuppressive effect of D-penicillamine when used in pregnancy.
    Yalaz M, Aydogdu S, Ozgenc F, Akisu M, Kultursay N, Yagci RV.
    Minerva Pediatr; 2003 Dec; 55(6):625-8. PubMed ID: 14676735
    [Abstract] [Full Text] [Related]

  • 24. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
    Lozano Herrero J, Muñoz Bertrán E, Ortega González I, Gómez Espín R, López Espín MI.
    Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
    [Abstract] [Full Text] [Related]

  • 25. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
    Berger B, Mader I, Damjanovic K, Niesen WD, Stich O.
    Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
    Leinweber B, Möller JC, Scherag A, Reuner U, Günther P, Lang CJ, Schmidt HH, Schrader C, Bandmann O, Czlonkowska A, Oertel WH, Hefter H.
    Mov Disord; 2008 Jan; 23(1):54-62. PubMed ID: 17960799
    [Abstract] [Full Text] [Related]

  • 27. Wilson's disease: clinical, genetic and pharmacological findings.
    Leggio L, Addolorato G, Abenavoli L, Gasbarrini G.
    Int J Immunopathol Pharmacol; 2005 Jan; 18(1):7-14. PubMed ID: 15698506
    [Abstract] [Full Text] [Related]

  • 28. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A, Curiel B, Berkowitz D, Levine A, Sack J, Lorberboym M.
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [Abstract] [Full Text] [Related]

  • 29. Pregnancy and Wilson's disease.
    Chin RK.
    Am J Obstet Gynecol; 1991 Aug; 165(2):488-9. PubMed ID: 1872365
    [No Abstract] [Full Text] [Related]

  • 30. Wilson's Disease: A Review for the General Pediatrician.
    Capone K, Azzam RK.
    Pediatr Ann; 2018 Nov 01; 47(11):e440-e444. PubMed ID: 30423186
    [Abstract] [Full Text] [Related]

  • 31. Central pontine signal changes in Wilson's disease: distinct MRI morphology and sequential changes with de-coppering therapy.
    Sinha S, Taly AB, Ravishankar S, Prashanth LK, Vasudev MK.
    J Neuroimaging; 2007 Oct 01; 17(4):286-91. PubMed ID: 17894614
    [Abstract] [Full Text] [Related]

  • 32. Pregnancy in a patient with treated Wilson's disease: a case report.
    Dupont P, Irion O, Béguin F.
    Am J Obstet Gynecol; 1990 Nov 01; 163(5 Pt 1):1527-8. PubMed ID: 2240101
    [Abstract] [Full Text] [Related]

  • 33. Penicillamine: the treatment of first choice for patients with Wilson's disease.
    Walshe JM.
    Mov Disord; 1999 Jul 01; 14(4):545-50. PubMed ID: 10435489
    [No Abstract] [Full Text] [Related]

  • 34. Wilson's disease with depression and parkinsonism.
    Chan KH, Cheung RT, Au-Yeung KM, Mak W, Cheng TS, Ho SL.
    J Clin Neurosci; 2005 Apr 01; 12(3):303-5. PubMed ID: 15851088
    [Abstract] [Full Text] [Related]

  • 35. Hepatolenticular degeneration (Wilson's disease) and pregnancy. A review and report of a case.
    Toaff R, Toaff ME, Peyser MR, Streifler M.
    Obstet Gynecol Surv; 1977 Aug 01; 32(8):497-507. PubMed ID: 331163
    [Abstract] [Full Text] [Related]

  • 36. Status epilepticus in Wilson's disease.
    Pestana Knight EM, Gilman S, Selwa L.
    Epileptic Disord; 2009 Jun 01; 11(2):138-43. PubMed ID: 19473947
    [Abstract] [Full Text] [Related]

  • 37. Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge!
    Srinivas K, Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Janardhana Reddy YC, Khanna S.
    J Neurol Sci; 2008 Mar 15; 266(1-2):104-8. PubMed ID: 17904160
    [Abstract] [Full Text] [Related]

  • 38. Penicillamine induced pseudo-pseudoxanthoma elasticum in a patient with Wilson's disease, which role plays the hepatologist?
    Ibáñez-Samaniego L, Ochoa-Palominos A, Catalina-Rodríguez MV, Salcedo-Plaza M, Clemente-Ricote G.
    Rev Esp Enferm Dig; 2015 Mar 15; 107(3):190-1. PubMed ID: 25733050
    [No Abstract] [Full Text] [Related]

  • 39. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB, Ekim M, Ensari A, Kuloglu Z, Yüksel S, Acar B, Kirsaçlioglu C, Kansu A, Yalçinkaya F, Girgin N.
    J Nephrol; 2006 Mar 15; 19(6):831-3. PubMed ID: 17173260
    [Abstract] [Full Text] [Related]

  • 40. Stereotypies in Wilson's disease.
    Yorio AA, Mesri JC, Pagano MA, Lera G.
    Mov Disord; 1997 Jul 15; 12(4):614-6. PubMed ID: 9251089
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.